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Abstract
Over the past decade, blood pressure and sodium intake declined among children and adolescents 
(ie, youths) in the United States. We updated temporal trends and determined if secular changes in 
blood pressure might be partly associated with usual sodium intake. We included 12 249 youths 
aged 8 to 17 years who participated in the National Health and Nutrition Examination Survey from 
2003 to 2016 and had blood pressure and dietary data. Logistic regression was used to describe 
secular trends and the association between usual sodium intake and blood pressure categorized 
according to 2017 Hypertension Guidelines. The prevalence of youths with combined elevated 
blood pressure/hypertension (ie, either elevated blood pressure or hypertension) significantly 
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declined from 16.2% in 2003-2004 to 13.3% in 2015-2016 (P<0.001 for trend), as did 
hypertension from 6.6% to 4.9% (P=0.005 for trend). Across the same time period, mean usual 
sodium intake decreased from 3381 to 3208 mg/day (P<0.001 for trend). Holding constant survey 
cycle, sex, age, race and Hispanic origin, and weight status, the adjusted odds ratio per 1000 
mg/day of usual sodium intake for elevated blood pressure/hypertension was 1.18 (95% CI, 1.03–
1.35) and for hypertension was 1.20 (95% CI, 0.96–1.50). From 2003 to 2016, blood pressure and 
usual sodium intake declined among youths. Although 1000 mg/day higher usual sodium intake 
was associated with ≈20% higher odds of elevated blood pressure/hypertension and hypertension, 
the association with hypertension was not statistically significant.
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Hypertension is a well-known risk factor for heart disease and stroke, which combined 
account for more deaths each year than any other major cause of death in the United States.1 
Although hypertension in children and adolescents (hereafter referred to as youths) is less 
common than in adults, evidence suggests higher blood pressure (BP) levels in childhood are 
associated with higher BP levels later in life.2 Previous research has demonstrated a linear, 
dose-dependent relationship between sodium intake and BP in adults and that sodium intake 
is associated with BP in children.3 Over the period of 1999 to 2012, evidence has suggested 
both sodium intake4 and BP5,6 declined slightly among US youths. Whether current 
temporal trends in BP (up to 2016) might be associated with concurrent changes in 
population sodium intake is unclear.
Though several studies described temporal changes in BP among US youths,5-7 few 
examined concurrent trends in sodium intake.7,8 To our knowledge, only one examined 
temporal trends in BP before and after adjusting for sodium intake.7 In this study, sodium 
intake was adjusted for energy intake (both estimated from a single 24-hour dietary recall) 
and differences in BP were examined between 1988-1994 and 1999-2008.7 The use of a 
single 24-hour recall does not represent usual intake and may have attenuated the true 
association between sodium and BP because of the high, within-person, day-to-day 
variability in foods consumed.8 Furthermore, evidence suggests that although BP increased 
between 1988-1994 and 1999-2008, declines occurred from 2007 to 2012.5,6 We 
hypothesized that current temporal trends in BP among US youths might be partly 
associated with shifts in the distribution of usual sodium intake.
The objectives of this study were to describe among US youths aged 8 to 17 years (1) 
temporal trends in estimated usual sodium intake from 2003 through 2016, (2) concurrent 
temporal trends in elevated BP (EBP) or hypertension, and (3) to determine if temporal 
trends in EBP or hypertension were correlated with usual dietary sodium intake.
Methods
We used data from the National Health and Nutrition Examination Survey (NHANES), a 
nationally representative, multistage survey of the noninstitutionalized US civilian 
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population.9 All participants provided written informed consent (parental consent was 
obtained for those <18 years) and NHANES was approved by the National Center for Health 
Statistics’ Ethics Review Board. Detailed information on NHANES data collection and 
survey procedures used in this analysis are publically available and can be found elsewhere.
10,11
 For our analyses, we used data collected from youths aged 8 to 17 years, publically 
released in 2-year cycles from 2003 to 2004 through 2015 to 2016. Exclusion criteria and 
additional methods are available in the online-only Data Supplement (Figure S1 and 
Methods in the online-only Data Supplement, respectively). For the purposes of reproducing 
this analysis, the analytic code used in this study is available from the corresponding author 
on request.
Measures
Dietary intake was assessed using up to two 24-hour dietary recalls collected using methods 
described previously.4 Nutrient values were assigned to foods and beverages using the 
United States Department of Agricultures’ Food and Nutrient Database for Dietary Studies 
corresponding with each 2-year cycle. Methods to estimate individual sodium intake 
changed over the time course of this study, but appropriate data files were used to ensure 
comparable methods for estimates of sodium intake from 2003 to 2016 (Methods in the 
online-only Data Supplement). Individual nutrient intake on each recall day was estimated 
by summing the amount of the specified nutrient consumed from each reported food and 
beverage for the previous 24-hour period. Total sodium intake excluded sodium from 
supplements, antacids, and salt added at the table. The National Cancer Institute’s method 
(Methods in the online-only Data Supplement), which accounts for within-person and day-
to-day variability, was used to estimate usual daily nutrient intake for each individual in 
nonlinear mixed effects models. Using this method, we estimated usual daily sodium intake, 
sodium density, daily energy intake, daily potassium intake, and sodium-potassium ratio.
A certified examiner obtained up to 3 consecutive BP measurements from participants ≥8 
years old using an appropriate cuff size and a mercury manometer, after the patient rested 
for 5 minutes in the seated position with feet flat on the floor.11 As described in the Methods 
(in the online-only Data Supplement), minor changes in BP measurement took place over 
the time course of the study and were not anticipated to affect estimates. Using the 2017 
American Academy of Pediatrics guidelines, we classified participants according to their BP 
percentiles for age, sex, and height and then as having hypertension, EBP, or normal BP 
(Table S1).12 To coincide with previous reports, we combined participants classified as 
having EBP or hypertension into 1 group which we classified as having EBP/hypertension. 
We also characterized BP using the former 2004 National Heart Lung and Blood Institute 
guideline criteria13 to compare estimates with previous publications (Table S1).
Covariates
As potential covariates, we selected age, sex, race and Hispanic origin, and weight status a 
priori due to the association of these characteristics with BP. We examined trends among 
Mexican-Americans in accordance with analytic guidelines related to the sampling design.14 
To assess weight status, we compared participants’ body mass index in kg/m2 to age- and 
sex-specific reference values from the 2000 Centers for Disease Control and Prevention 
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growth charts.15 Under/normal weight was defined as body mass index for age/sex <85th 
percentile, overweight as ≥85th to <95th, and obesity as ≥95th. Several variables of interest 
(ie, self-reported frequency of salt added at the table, poverty-income ratio, and physical 
activity) were only available among a subset of included participants and were examined in 
sensitivity analyses (Tables S6 through S8).
Statistical Analyses
We examined frequencies and SE of selected covariates, mean (SE) of usual nutrient intake 
indicators, and the prevalence (SE) of EBP/hypertension and hypertension by 2-year survey 
cycle. Regression models are described in the online-only Data Supplement. Unadjusted and 
multiple logistic regression models with predicted marginals were used to examine 
frequencies/prevalence of sociodemographic variables and EBP/hypertension by 2-year 
survey cycle, whereas least squares linear regression models were used to examine mean 
usual nutrient intakes. We adjusted for age (years) when examining temporal trends in 
sociodemographic characteristics, weight status, EBP/hypertension, and hypertension, and 
for survey cycle, age (years), sex, race, and Hispanic origin, and weight status when 
examining temporal trends in usual sodium intake. Linear and quadratic trends were tested 
using orthogonal contrast matrices. Next, the associations between indicators of usual 
sodium intake and EBP/hypertension or hypertension were examined using logistic 
regression adjusted for survey cycle, sociodemographic characteristics, weight status, and 
estimated usual energy or potassium intake as applicable.16 Lastly, logistic regression 
models were used to examine temporal trends in EBP/hypertension or hypertension per 
survey cycle, successively adjusting for (1) sociodemographic characteristics, (2) weight 
status, and (3) indicators of usual sodium intake (including usual energy or potassium intake 
as applicable).
Statistical analyses were conducted using statistical software (SAS callable SUDAAN, 
version 11) to account for the complex survey design. Fourteen-year sample weights for 
NHANES 2003 to 2016 (constructed from day 1 dietary sample weights), were used to 
account for unequal sampling probabilities, nonresponse, noncoverage, and sample design. 
We calculated relative SE and according to recommendations: defined unstable estimates, 
which should be interpreted with caution, as 30%< relative SE ≤40% and suppressed 
estimates with relative SE >40%.14 Reported P values were not adjusted for multiple 
comparisons and are based on the Satterthwaite adjusted F test. All tests are 2 sided, and a 
P<0.05 was considered statistically significant.
Results
The final sample included 12 249 US youths with a mean age of 12.6 years. Compared with 
those excluded, higher proportions of included youths were 13 to 17 years, (51.5% versus 
38.2%) white, non-Hispanic (27.9% versus 23.8%), and under/normal weight (61.0% versus 
50.8%; P<0.001, overall difference by characteristic; Table S2). Among included youths, 
sex, age, and weight status distributions were similar from 2003 to 2004 through 2015 to 
2016 (P>0.05 for temporal trend; Table 1, sample sizes in Table S3), but the proportion of 
white, non-Hispanic youths declined ≈11% (P=0.032 for trend).
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Among youths, usual mean daily sodium intake declined from 3381 mg in 2003 to 2004 to 
3208 mg in 2015 to 2016 (Table 2). Holding demographic characteristics and weight status 
constant, usual mean daily sodium intake declined, on average, by 35 mg per 2-year survey 
cycle (P<0.001 for linear trend; Table 2). Similar temporal linear declines in usual mean 
daily sodium intake occurred among all subpopulations explored (Table 2). In post hoc 
exploratory analyses, usual daily sodium density slightly increased from 2003 to 2016 
(P<0.001 for trend), whereas sodium-to-potassium ratios, energy, and potassium intake 
declined (P<0.05 for trend; Table S4).
Overall, the prevalence of youths with EBP/hypertension declined from 16.2% in 2003 to 
2004 to 13.3% in 2015 to 2016 (P<0.001 for trend), as did hypertension, from 6.6% to 4.9% 
(P=0.005 for trend; Table 3). Similarly, using the former criteria, the EBP/hypertension 
prevalence and hypertension declined over this time period (Table S5). In exploratory 
analyses, significant temporal declines occurred in EBP/hypertension prevalence among 
most subgroups with a few exceptions: among Mexican-American youths or those who were 
overweight, temporal linear trends were not significant. Temporal linear trends in the 
prevalence of hypertension were inconsistent across other subgroups, and some prevalence 
estimates were statistically unreliable (Table 3).
EBP/hypertension was significantly associated with usual sodium intake among youths 
(Table 4). Holding constant survey cycle, sex, age, race and Hispanic origin, and weight 
status, an additional 1000 mg of sodium consumed per day was associated with 18% higher 
adjusted odds ratio (AOR) of EBP/hypertension (1.18; 95% CI, 1.03–1.35). The AOR for 
hypertension was 1.20 (0.96–1.50). Additionally adjusting for energy intake, the AORs per 
1000 mg sodium consumed per day were 1.39 (1.08–1.80) for EBP/hypertension and 1.33 
(0.89–1.98) for hypertension (Table 4). The AOR for EBP/hypertension per mg of sodium 
per 1000 kcal consumed was 2.53 (1.14–5.60) and per unit difference in the molar ratio of 
sodium-to-potassium intake was 1.35 (1.12–1.64; Table 4). The AOR for hypertension per 
unit difference in the molar ratio of sodium-to-potassium intake was 1.58 (1.13–2.21).
The AORs for EBP/hypertension per 2-year survey cycle from 2003 to 2016 were 0.91 
(0.86–0.96) when adjusting for sociodemographic characteristics and weight status (model 
2) and 0.91 (0.87–0.96) additionally adjusting for usual sodium intake (model 3) and were 
similar for other sodium intake measures (models 4–7; Table 5). The AOR for hypertension 
per 2-year survey cycle also was similar across models.
Sensitivity Analyses
The frequency of youths adding salt at the table changed over this time period. Among the 
subset of participants with data, temporal trends in poverty-income ratio were not 
significant, and inactivity significantly increased (Table S6).
The AORs for EBP/hypertension and hypertension per 1000 mg of usual sodium intake were 
similar before and after adjusting for poverty-income ratio and physical activity status. 
Adjusting for table salt use, the AOR for hypertension with higher usual sodium intake was 
similar, whereas EBP/hypertension became nonsignificant (P=0.344; Table S7). The AOR 
Overwyk et al. Page 5
Hypertension. Author manuscript; available in PMC 2019 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
for EBP/hypertension per survey cycle remained similar before and after adjusting for table 
salt use, poverty-income ratio, or physical activity status (Table S8).
Discussion
From 2003 to 2016, we observed significant linear declines in both EBP/hypertension and 
hypertension among a nationally representative sample of US youths. A slight, but 
statistically significant, temporal linear decline also occurred in usual sodium intake. 
Although usual sodium intake was positively associated with EBP/hypertension, the 
temporal linear decline in BP was similar before and after adjusting for usual sodium intake. 
These results suggest recent temporal linear declines in EBP/hypertension were not 
correlated with the small linear decline in usual population sodium intake.
This study updates temporal trends in sodium intake and EBP/hypertension prevalence up to 
2015-2016. Although there are differences in the estimation of sodium intake, definitions of 
EBP/hypertension, years included, and population subgroups examined, in general, our 
study results seem consistent with published trends through 2012, with 1 exception.4-7 
Unlike our study, Xi et al6 suggested mean population sodium intake did not decline 
between 2003 and 2012; however, these results might be explained by not accounting for 
adjustments for salt added during cooking, which could have led to an artificial increase in 
sodium intake before 2009. Our results are similar to a previous study which also used 
methods to ensure consistency in sodium estimation over time.4 Though mean sodium intake 
slightly declined through 2016, the decline seemed to be related to a lower energy intake 
rather than less consumption of sodium dense foods.4 Although the sodium content of some 
US foods declined, reductions are inconsistent and improvements in diet quality of youths 
may be primarily driven by decreased empty calorie, and increased whole fruit, 
consumption.17,18
Our results are consistent with recent prevalence estimates among US youth,19,20 with 1 
exception. In 2011 to 2012, EBP/hypertension prevalence was slightly higher in our study 
compared with previous estimates, perhaps attributed to the use of different definitions for 
EBP/hypertension.5,6 The lack of significant decline among Mexican-American youths is 
consistent with previous research through 2012 despite differences in samples, race 
categorization (ie, Hispanic), and EBP/hypertension definitions6 This could be due to a 
slightly higher proportion of Mexican-American overweight youths (19% versus 16% in 
non-Hispanic white youths), as EBP/hypertension also did not decline over time among 
overweight participants. Furthermore, the temporal declines in usual sodium intake were 
smallest among Mexican-American youths and those who were overweight, which might 
explain the lack of a secular trend in EBP/hypertension in these groups. Additionally, the 
EBP/hypertension prevalence and hypertension were significantly lower in 2013 to 2014 
compared with other survey cycles, potentially due to the higher level of physical activity 
seen in 2013 to 2014, chance, or other factors.
To our knowledge, the correlation between temporal trends in BP and sodium intake among 
US youths has only been investigated in one other study, using NHANES data preceding 
2009.7 Similar to our results, this study indicated after adjusting for demographic 
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characteristics, body mass index Z score, and waist circumference Z score, further adjusting 
for sodium intake did not change temporal trends in BP, despite a positive association 
between BP and sodium intake. Potential reasons for the lack of correlation in the current 
study are unexplained measurement error, the small magnitude of the decline (<250 mg/day) 
in usual sodium intake over the time period, or a true null association.
In the current study, usual sodium intake was modestly associated with EBP/hypertension. 
The odds for EBP/hypertension adjusting for energy and other characteristics were 
consistent with the 36% higher odds seen in a previous study, despite differences in 
methods.7 Additionally, the associations of EBP/hypertension with the molar ratio of 
sodium-to-potassium and when additionally holding potassium intake constant suggests 
sodium intake is associated with EBP/hypertension independent of potassium intake.
Our study has some limitations. Although data were weighted to account for nonresponse, 
NHANES participants may differ from nonparticipants. In our study, hypertension was 
defined using up to 3 BP readings on a single visit; whereas, a clinical diagnosis requires 
confirmed readings on 3 separate occasions.12 This could result in misclassification of some 
participants, potentially attenuating observed associations with sodium intake. Dietary 
recalls can be subject to errors in reporting and nutrient estimation.21 Bias from self-reported 
intake rather than true dietary sodium intake may attenuate the true association between 
sodium and BP.8 Usual sodium intake estimation did not account for the amount of sodium 
consumed from salt added at the table, estimated to contribute ≈5% of total sodium intake.22 
We could not account for several covariates among the full sample of participants, including 
income, physical activity, and use of antihypertensive medication. Given the low prevalence 
(<1%) of antihypertensive use among adolescents aged 16 to 17 years, it is doubtful that 
increases in medication use could explain the decline in BP. The sample sizes in certain 
subgroups were small diminishing the reliability of hypertension prevalence estimates for 
some 2-year survey cycles. Additionally, low statistical power or prevalence may explain the 
lack of statistically significant associations for some outcomes. However, lack of correction 
for multiple comparisons could increase the likelihood of statistically significant results due 
to chance.23
Lifestyle modifications, such as maintaining a healthy weight, consuming a Dietary 
Approaches to Stop Hypertension-type eating pattern, limiting sodium, and increasing 
physical activity, are reasonable strategies for hypertension prevention.12 As indicated by the 
small decline in sodium observed in our study, additional efforts may be required to achieve 
substantive reductions in sodium intake. Reformulation efforts could support sodium 
reduction activities as the majority of sodium intake among US youths is estimated to come 
from salt added to commercially processed foods.24,25 Additionally, clinician advice can 
support sodium reduction efforts through increased consumer awareness and motivation to 
make healthier choices.12,24,26 This study, along with previous studies,3,7 indicate higher 
sodium intake is associated with EBP/hypertension, supporting efforts to reduce population 
sodium intake.
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Perspectives
To our knowledge, this is the first study to assess concurrent temporal trends through 2016 
in usual sodium intake and EBP/hypertension defined using the 2017 BP guidelines and to 
determine if trends were correlated. The decline in EBP/hypertension from 2003 to 2016 
was not correlated with usual sodium intake, potentially due to the relatively small decline in 
sodium intake (≈35 mg/survey cycle). As population distributions of covariates examined 
were similar over this time period, they also did not account for BP declines. As a greater 
proportion of youths are classified with EBP/hypertension under the current new guidelines, 
understanding the contributions of lifestyle factors to temporal decreases could help achieve 
further declines. Expanding assessment of physical activity and potentially medication use 
among US youths in nationally representative surveys might help us better understand the 
contribution of these factors and how they interact with diet in the prevention of EBP/
hypertension.
Supplementary Material
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Novelty and Significance
What Is New?
• Temporal trends in elevated blood pressure (EBP)/hypertension (ie, elevated 
blood pressure or hypertension) and usual sodium intake were updated 
through 2016 among a nationally representative sample of US youths.
• Significant temporal declines in EBP/hypertension were concurrent with 
slight temporal reductions in mean usual sodium intake.
• Higher usual sodium intake was associated with ≈20% higher EBP/
hypertension. Declines in EBP/hypertension from 2003 to 2016 were not 
correlated with the concurrent, but slight reductions (mean <250 mg/day over 
14 years) in usual population sodium intake.
What Is Relevant?
• About 1 in 8 youth have EBP/hypertension. Evidence suggests that EBP in 
childhood tracks with age and can increase the risk for high blood pressure in 
adults, a major risk factor for heart disease and stroke.
• As American youth consume ≈3208 mg of sodium/day, continued efforts are 
needed to lower intake. Clinicians can provide dietary counseling to reduce 
sodium consumption to enhance patients’ efforts to prevent EBP.
Summary
Modest declines in BP and usual sodium intake were observed from 2003 to 2016 among 
US youths. The results from this study indicate that usual sodium intake is associated 
with BP. The small decline in sodium observed over this time period suggests that 
additional efforts are required to reduce sodium intake among this population. Future 
studies examining other lifestyle factors are warranted to help us understand how these 
factors may contribute to prevention efforts.
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